How to Value a Startup: Methods That Actually Work

Summary

Valuing a startup is not the same problem as valuing a business. A profitable company has earnings to multiply and cash flow to discount. A startup, especially before revenue, has neither, so the standard toolkit of EBITDA multiples and discounted cash flow either breaks outright or produces a number so sensitive to assumptions that it means nothing.

Startup valuation is therefore its own discipline. It leans on qualitative benchmarks for the earliest stages, works backward from a plausible exit for growth-stage companies, and always expresses the answer as a range built from scenarios rather than a single confident point. This guide walks through the methods that actually apply, when to use each one, and how to reconcile them into a number you can defend across a term-sheet negotiation.

If you want a fast, grounded starting point before you dig in, run the business valuation calculator to anchor your thinking in real data. Then come back and apply the startup-specific methods below.

Why earnings multiples and DCF break down

The default methods for valuing an operating business rest on two assumptions: that the company has stable earnings, and that its future cash flow is predictable enough to forecast. A startup violates both.

• There is nothing to multiply. A pre-revenue company has no earnings, and often no revenue. An EBITDA multiple applied to a negative number is meaningless, and even a revenue multiple has no revenue to work with at the earliest stage.
• DCF collapses under its own sensitivity. You can build a discounted cash flow for a startup, but nearly all of the value sits in a terminal value five or ten years out. Change the growth rate by a few points or the discount rate by a few percent and the answer moves by an order of magnitude. A model that swings that hard on unknowable inputs is not a valuation, it is a guess with a spreadsheet attached.
• The risk profile is binary. Most startups fail. A handful return the entire fund. Averaging methods that assume a smooth, going-concern outcome miss the shape of the actual outcome distribution, which is why scenario weighting matters so much here.

The lesson is not that DCF and multiples are useless. It is that they only start to apply once a startup has real, recurring revenue and a growth curve you can extrapolate. Before that, you need methods built for uncertainty.

Match the method to the stage

Stage is the single most important input. It determines how much evidence you have and therefore which methods carry weight.

The pattern is clear. At the earliest stages you have almost no quantitative signal, so you rely on qualitative frameworks and market comparables. As revenue and a growth curve appear, you can shift weight onto multiples and scenario-weighted analysis, and DCF finally becomes a sanity check rather than the main event.

Value pre-revenue startups with Scorecard and Berkus

Before revenue, two frameworks do most of the work. Both convert qualitative judgment into a pre-money number in a structured, repeatable way.

The Scorecard method starts from the average pre-money valuation of recently funded startups at the same stage and region, then adjusts that baseline up or down across weighted factors: the strength of the management team, the size of the opportunity, the product and technology, the competitive environment, and any early traction. If your team and market are clearly above the regional average, you scale the baseline up; if the product is unproven, you scale it down. The output is a pre-money valuation grounded in what comparable companies actually raised at.

The Berkus method takes a different route. It assigns a capped dollar value, commonly up to a few hundred thousand each, to five risk-reducing milestones:

• A sound basic idea (value in the concept itself).
• A working prototype (reduces technology risk).
• A quality management team (reduces execution risk).
• Strategic relationships (reduces market risk).
• Product rollout or early sales (reduces production risk).

Add them up and you get a pre-money value that rewards concrete de-risking rather than a pitch. Run both methods, cross-check them against each other, and reconcile any gap against recent comparable rounds. When Scorecard and Berkus disagree sharply, that disagreement is telling you which risks are still unpriced.

Work backward from an exit with the VC method

Once a startup has enough of a plan to project an exit, the VC method becomes the workhorse. Instead of valuing the company on what it is today, it values the company on what a realistic exit would be worth, then discounts that back hard.

The logic runs in four moves:

1. Estimate the exit value. Project revenue or earnings five to seven years out and apply an exit multiple drawn from real acquisitions or IPOs of comparable companies. This is the terminal outcome the investment is chasing.
2. Apply a venture required return. Discount that exit value back to today at a rate that reflects venture risk, typically 30 to 60 percent per year. The rate is high because most startups return nothing, and the winners have to cover the losers.
3. Subtract expected dilution. Future rounds will issue new shares. An investor today will own a smaller percentage at exit than they buy now, so you haircut the value for that expected dilution.
4. Solve for today's post-money. The result is the most an investor can pay now and still hit their target return, which sets the post-money valuation for the current round.

The VC method makes the exit assumption explicit, which is its great strength. It forces everyone at the table to agree on what "good" looks like and how far away it is.

Apply revenue and ARR multiples once traction is real

When a startup has genuine, recurring revenue, especially a SaaS company, revenue multiples become the most direct market-based method. The cleanest version for SaaS is the ARR multiple: take annualized recurring revenue and apply a multiple drawn from comparable financings and acquisitions.

The multiple is not a fixed sector number. It moves with quality:

• Growth rate. A company doubling year over year supports a far higher multiple than one growing 20 percent, at the same revenue.
• Net revenue retention. Above 100 percent means the existing customer base expands on its own, which the market pays a premium for.
• Gross margin. Software-grade margins support higher multiples than services-heavy revenue.
• Burn efficiency. How much cash the company burns to add a dollar of recurring revenue signals how durable the growth is.

A clean example: ARR of $2M at a growth-adjusted 8x multiple implies a roughly $16M valuation, before adjusting for anything specific to the company. Then ask whether this startup deserves a premium or a discount to comparable rounds, and move the multiple accordingly. Treat any published multiple as a starting point, never a fact.

Anchor to comparable financings and weight the scenarios

Two methods hold the whole exercise together: comparable rounds, which ground everything in market reality, and the First Chicago method, which handles the binary risk profile honestly.

Comparable financings and transactions are the market evidence. Collect the pre-money valuations of recent rounds for companies at the same stage, sector, and geography, plus any acquisition multiples in the space. These are the most persuasive numbers in a negotiation, because they reflect what investors actually funded and what buyers actually paid. Every other method should be reconciled against them.

The First Chicago method confronts the fact that a startup has a wide, lumpy range of outcomes. Instead of a single forecast, you build three:

• A downside case where the company survives but underdelivers, or exits small.
• A base case that reflects the plausible central outcome.
• An upside case that models the breakout success.

Value each scenario on its own merits, assign a probability to each, and take the probability-weighted average. This does two things a single forecast cannot: it stops the upside case from dominating the story, and it prices the real chance of failure directly into the number. The output is naturally a range, which is exactly what a startup valuation should be.

Model dilution and the option pool

A pre-money valuation is not what founders or early investors keep. Two forces sit between the headline number and the value anyone actually retains, and both must be modeled.

• The option pool top-up. Investors typically require you to create or expand an employee option pool before the round closes, sized to cover the next couple of years of hiring. This pool comes out of the pre-money valuation, which means founders are diluted before the new money even arrives. A "$10M pre-money" with a 15 percent pool top-up is a materially different deal than the same pre-money with no new pool.
• Future round dilution. Every subsequent round issues new shares. An investor buying 20 percent today may hold well under that at exit after two or three more rounds. Founders feel this most acutely, since they start at 100 percent and are diluted at every step.

This is why a serious startup valuation models the cap table forward, not just the current round. The headline pre-money number and the founder's actual retained value at exit are two very different figures, and conflating them is one of the most common and expensive mistakes founders make.

Reconcile into a range and stress-test it

Now you have several answers that disagree, which is normal and useful. As with any valuation, the job is not to pick a winner but to reconcile them into a defensible range.

Weight the methods by how much signal you have. For a pre-revenue company, lean on Scorecard, Berkus, and comparable rounds. For a growth-stage company with real ARR, lean on revenue multiples, the VC method, and First Chicago, using DCF only as a distant sanity check. Produce a low, base, and high estimate rather than a single point. A value expressed as "$12M to $20M, base $16M" is far more defensible and far more useful in a fundraising conversation than one confident-sounding figure.

Then stress-test it. Flex the three inputs the valuation is most sensitive to: the exit multiple, the growth rate, and the scenario probabilities. Watch how far the value swings when the base case slips toward the downside, or when a longer time to exit compounds the discount rate. Seeing where the number is exposed tells you which assumptions you most need to defend, and it arms you for the questions any serious investor will ask.

Ready to value your startup?

You can run this full process by hand, and before any real fundraise it is worth doing. But for a fast, grounded starting point, run the business valuation calculator to anchor your range in real data before you layer in the startup-specific methods above. Either way the discipline is the same: fix the stage, run the methods that fit it, weight the scenarios, model the dilution, and reconcile everything into a range you can defend, not a single number you are hoping for.